Compound ID | 154
Class: Nanoparticles (silver) citrate capped
| Spectrum of activity: | Gram-negative |
| Details of activity: | Works in contrast with antibiotics to target Pseudomonas aeruginosa PAO1 biofilms |
| Combined with other compounds: | Yes |
| Institute where first reported: | School of Environmental Sciences, University of Guelph, Guelph, Ontario, Canada AND SEPERATELY Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| External links: | |
| Citations: |
|